NUTRALOID LABS, INC. – Trademark Portfolio
Entity Type: 03
NUTRALOID LABS, INC. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 13 filings in this category. The portfolio also extends into Class 28 (Toys & Sporting Goods) across 2 Nice Classification classes. Currently, 7 trademarks are registered and 2 are pending. Notable registered marks include HERBEREX, EJACULOID, BICEP BOMBER, COLOSSAL LABS, and GOLIATH LABS.COM. The owner is based in Saugerties, NY.
2316 Route 9W
Saugerties, NY 12477
Showing of trademarks Trademarks
Trademark Classifications
NUTRALOID LABS, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does NUTRALOID LABS, INC. have?
NUTRALOID LABS, INC. has 14 U.S. trademarks filed with the USPTO. Of these, 7 registered, 2 pending, 4 abandoned, 1 cancelled.
What trademark classes does NUTRALOID LABS, INC. file in?
NUTRALOID LABS, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 28 (Toys & Sporting Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are NUTRALOID LABS, INC.'s most well-known trademarks?
NUTRALOID LABS, INC.'s registered trademark portfolio includes well-known marks such as HERBEREX, EJACULOID, BICEP BOMBER, COLOSSAL LABS, and GOLIATH LABS.COM. These are among 7 currently registered trademarks in the portfolio.
What is NUTRALOID LABS, INC.'s trademark registration success rate?
NUTRALOID LABS, INC. has a 58% trademark registration rate, with 7 out of 12 resolved applications resulting in successful registration. Currently, 2 applications are pending review.